MEDONCO Telegram 874
CLEAR trial, upd.
Метастатический почечно-клеточный рак, 1 линия, все группы.
PFS lenva + pembro vs sunitinib: mPFS 23.3m vs 9.2m, HR 0.42 [0.34-0.52], p<0.0001

https://www.sciencedirect.com/science/article/abs/pii/S1470204523000499?dgcid=author



tgoop.com/medonco/874
Create:
Last Update:

CLEAR trial, upd.
Метастатический почечно-клеточный рак, 1 линия, все группы.
PFS lenva + pembro vs sunitinib: mPFS 23.3m vs 9.2m, HR 0.42 [0.34-0.52], p<0.0001

https://www.sciencedirect.com/science/article/abs/pii/S1470204523000499?dgcid=author

BY Medical Oncology




Share with your friend now:
tgoop.com/medonco/874

View MORE
Open in Telegram


Telegram News

Date: |

Write your hashtags in the language of your target audience. Some Telegram Channels content management tips Developing social channels based on exchanging a single message isn’t exactly new, of course. Back in 2014, the “Yo” app was launched with the sole purpose of enabling users to send each other the greeting “Yo.” On June 7, Perekopsky met with Brazilian President Jair Bolsonaro, an avid user of the platform. According to the firm's VP, the main subject of the meeting was "freedom of expression." Channel login must contain 5-32 characters
from us


Telegram Medical Oncology
FROM American